Stock Alert: Biomerica Adds 14%

Shares of Biomerica, Inc. (BMRA) are rising more than 14% Tuesday morning after the company said it submitted Emergency Use Authorization (EUA) application to the FDA for its ELISA lab-based serology antibody test for Covid-19.